Position in MNOV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$28,189
+$27,435 QoQ
Shares Held
20,576
+3472.2% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNOV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in MNOV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,189 | 20,576 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $754 | 576 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $96 | 76 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $99 | 76 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $12,666 | 8,676 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,679 | 1,276 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $23,679 | 11,276 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $7,741 | 5,376 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $48,540 | 33,476 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $200,149 | 133,433 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $282,935 | 135,376 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $386,886 | 168,212 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $380,972 | 176,376 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $511,156 | 249,345 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $646,824 | 298,076 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $747,301 | 295,376 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $823,096 | 308,276 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $807,124 | 301,166 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,050,379 | 277,145 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,162,684 | 273,573 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,290,542 | 255,553 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $594,378 | 113,000 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $216,841 | 41,382 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $76,801 | 14,170 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $126,334 | 33,961 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||